CompletedNCT00249353
Methylphenidate or placebo for adolescents with ADHD
About this title
Read the official source — NCT00249353This study evaluated the safety and effectiveness of methylphenidate hydrochloride for people with ADHD.
Medication studyAges 13–18
Understand this study
What did researchers investigate?
This study evaluated the safety and effectiveness of methylphenidate hydrochloride for people with ADHD.
Who was this study for?
Listed age limits: 13 years to 18 years.
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateMarch 2002
- Recruitment status
- Completed
- Enrollment listed in the registry
- 220
- Sponsor
- McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Not clearly listed
- Age range
- From 13 Years to 18 Years
- Official registry ID
- NCT00249353
- Official title
Show the full official title
An Evaluation of the Safety and Effectiveness of CONCERTA® (Methylphenidate Hydrochloride), up to 72 mg Daily, in Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedLocations not listed
Questions about this study
What did researchers investigate?
This study evaluated the safety and effectiveness of methylphenidate hydrochloride for people with ADHD.
Who is behind this study?
The study sponsor is McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Did this study involve medication?
Yes. The study involved medication, including methylphenidate hydrochloride.
Who was this study for?
Listed age limits: 13 years to 18 years.
